Published in Lancet on May 03, 2008
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36
Clostridium difficile has two parallel and essential Sec secretion systems. J Biol Chem (2011) 1.50
Clostridium: transmission difficile? PLoS Med (2012) 0.97
Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther (2014) 0.92
Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica (Cairo) (2014) 0.91
Murine models to study Clostridium difficile infection and transmission. Anaerobe (2013) 0.89
Identification of a novel zinc metalloprotease through a global analysis of Clostridium difficile extracellular proteins. PLoS One (2013) 0.86
Regulation of Type IV Pili Contributes to Surface Behaviors of Historical and Epidemic Strains of Clostridium difficile. J Bacteriol (2015) 0.79
Cyclic diguanylate signaling in Gram-positive bacteria. FEMS Microbiol Rev (2016) 0.77
Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection. World J Gastrointest Pathophysiol (2015) 0.76
Clostridium difficile bacteremia: Report of two cases in French hospitals and comprehensive review of the literature. IDCases (2017) 0.75
The role of Clostridium difficile in the paediatric and neonatal gut - a narrative review. Eur J Clin Microbiol Infect Dis (2016) 0.75
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol (2002) 3.24
Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol (2010) 1.59
The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol (2012) 1.40
Safety and acceptability of the Reality condom for anal sex among men who have sex with men. AIDS (2003) 1.28
Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am (2006) 1.06
Clostridium difficile infection in the elderly. Clin Geriatr Med (2014) 1.05
Emerging infections of the gastrointestinal tract. Best Pract Res Clin Gastroenterol (2009) 1.00
Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease. Am J Gastroenterol (2003) 0.95
Updates on treatment of irritable bowel syndrome. World J Gastroenterol (2008) 0.94
Clostridium difficile Infection. Med Clin North Am (2013) 0.90
Treatment strategies for C. difficile associated diarrhea. Acta Gastroenterol Latinoam (2007) 0.85
Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Rev Gastroenterol Hepatol (2013) 0.85
Infectious diarrhea: an overview. Curr Gastroenterol Rep (2014) 0.83
Evolving concepts in Clostridium difficile colitis. Curr Gastroenterol Rep (2009) 0.83
Reining in recurrent Clostridium difficile infection--who's at risk? Gastroenterology (2009) 0.82
Infectious causes of chronic diarrhoea. Best Pract Res Clin Gastroenterol (2012) 0.81
Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol (2014) 0.81
Chronic diarrhea. Clin Gastroenterol Hepatol (2005) 0.80
Antibiotic-associated diarrhea in children: how many dirty diapers? J Pediatr Gastroenterol Nutr (2003) 0.80
Antibiotics and Clostridium difficile: cause and cure. J Clin Gastroenterol (2007) 0.78
The gut microbiome: a clinically significant player in transplantation? Expert Rev Clin Immunol (2015) 0.78
Current Treatment Options for Severe Clostridium difficile-associated Disease. Gastroenterol Hepatol (N Y) (2008) 0.77
The gut microbiota: a microbial arsenal protecting us from infectious and radiation-induced diarrhea. Gastroenterology (2008) 0.77
Loperamide use for acute infectious diarrhea in children: safe and sound? Gastroenterology (2008) 0.76
The changing face of Clostridium difficile: what treatment options remain? Am J Gastroenterol (2007) 0.76
Do we need our gastric acid? Risk of bacterial gastroenteritis with proton pump inhibitors. Gastroenterology (2008) 0.75
Irritable bowel syndrome: a chronic sequelae of acute gastroenteritis. Gastroenterology (2007) 0.75
The acid test: is proton pump inhibitor therapy an independent risk factor for Clostridium difficile-associated disease? Gastroenterology (2007) 0.75
Infection: treating recurrent C. difficile infection-the challenge continues. Nat Rev Gastroenterol Hepatol (2012) 0.75
Shigella: a sexually transmitted infection in men who have sex with men. Gastroenterology (2007) 0.75
Emergency colectomy in severe Clostridium difficile-associated disease: the sooner the better for some. Gastroenterology (2007) 0.75
C difficile--C'est Difficile? Gastroenterology (2006) 0.75
Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis. Am J Gastroenterol (2010) 0.75
Cytomegalovirus in inflammatory bowel disease: time for another look? Gastroenterology (2009) 0.75
Fecal microbiota transplantation: what we know and what we need to know. Ann Intern Med (2015) 0.75
Probiotics and prebiotics in clinical practice. Nutr Clin Care (2004) 0.75
Diagnosis of celiac disease in a patient with fecal incontinence. Nat Clin Pract Gastroenterol Hepatol (2006) 0.75
Maintenance infliximab infusions forever? Am J Gastroenterol (2002) 0.75
Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea. Expert Rev Gastroenterol Hepatol (2007) 0.75